311 related articles for article (PubMed ID: 23350049)
1. Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire.
Jo SY; Kim N; Lim JH; Shin CM; Park YS; Lee DH; Jung HC
J Neurogastroenterol Motil; 2013 Jan; 19(1):61-9. PubMed ID: 23350049
[TBL] [Abstract][Full Text] [Related]
2. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
Triadafilopoulos G; Kamal A; Clarke JO
Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
[TBL] [Abstract][Full Text] [Related]
3. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
4. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
Lee KJ; Kwon HC; Cheong JY; Cho SW
Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
[TBL] [Abstract][Full Text] [Related]
5. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
Roorda AK; Marcus SN; Triadafilopoulos G
Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
[TBL] [Abstract][Full Text] [Related]
6. [The characteristics of esophagogastric junction contractile index in patients with gastroesophageal reflux disease or functional heartburn].
Wang K; Duan LP; Ge Y; Xia ZW; Xu ZJ
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):283-8. PubMed ID: 27030616
[TBL] [Abstract][Full Text] [Related]
7. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis.
Yang M; Li ZS; Chen DF; Zou DW; Xu XR; Fang DC; Xu GM; Stephens RL; Wang ZG
Clin J Pain; 2010 May; 26(4):326-31. PubMed ID: 20393268
[TBL] [Abstract][Full Text] [Related]
9. Association of sleep dysfunction and emotional status with gastroesophageal reflux disease in Korea.
Kim JY; Kim N; Seo PJ; Lee JW; Kim MS; Kim SE; Jo SY; Lee DH; Jung HC
J Neurogastroenterol Motil; 2013 Jul; 19(3):344-54. PubMed ID: 23875102
[TBL] [Abstract][Full Text] [Related]
10. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.
Savarino E; Zentilin P; Mastracci L; Dulbecco P; Marabotto E; Gemignani L; Bruzzone L; de Bortoli N; Frigo AC; Fiocca R; Savarino V
J Gastroenterol; 2013 Apr; 48(4):473-82. PubMed ID: 23001252
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of response to proton pump inhibitors in korean patients with gastroesophageal reflux disease.
Kim SE; Kim N; Oh S; Kim HM; Park MI; Lee DH; Jung HC
J Neurogastroenterol Motil; 2015 Jan; 21(1):69-77. PubMed ID: 25537676
[TBL] [Abstract][Full Text] [Related]
12. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.
Kusano M; Hosaka H; Kawamura O; Kawada A; Kuribayashi S; Shimoyama Y; Yasuoka H; Mizuide M; Tomizawa T; Sagawa T; Sato K; Yamada M
J Gastroenterol; 2015 Mar; 50(3):298-304. PubMed ID: 24919745
[TBL] [Abstract][Full Text] [Related]
13. A single-center retrospective study on epidemiological and Traditional Chinese Medicine syndrome characteristics of 21010 patients with reflux/heartburn symptoms.
Yanping T; Peicai LI; Xi L; Lei L; Yanxia G; Xiaodong W; Lina L; Li Y
J Tradit Chin Med; 2023 Jun; 43(3):574-581. PubMed ID: 37147760
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
Miyamoto M; Manabe N; Haruma K
Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276
[TBL] [Abstract][Full Text] [Related]
15. [Long-term impact on quality of life in patients with gastroesophageal reflux disease after 52-week rabeprazole treatment].
Yang XL; Liu XH; Ke MY; Song ZQ; Yuan YZ; Luo JY; Hou XH
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2404-7. PubMed ID: 20137694
[TBL] [Abstract][Full Text] [Related]
16. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.
Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R
Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776
[TBL] [Abstract][Full Text] [Related]
17. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study.
Luo X; Guo XX; Wang WF; Peng LH; Yang YS; Uedo N
World J Gastroenterol; 2016 Apr; 22(14):3845-51. PubMed ID: 27076770
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
19. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring.
Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Furnari M; Martinucci I; Mirante VG; Marchi S; Savarino V; Savarino E
Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27620303
[TBL] [Abstract][Full Text] [Related]
20. Reflux profile of Chinese gastroesophageal reflux disease patients with combined multichannel intraluminal impedance-pH monitoring.
Xiao YL; Lin JK; Cheung TK; Wong NY; Hung IF; Wong BC; Peng S; Wang AJ; Chen MH
J Gastroenterol Hepatol; 2009 Jun; 24(6):1113-8. PubMed ID: 19638089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
